BRIEF-Vivani Medical Provides Update On Clinical Development Plans For Npm-139 Semaglutide Implant For Chronic Weight Management
Reuters
Sep 04
BRIEF-Vivani Medical Provides Update On Clinical Development Plans For Npm-139 Semaglutide Implant For Chronic Weight Management
Vivani Medical Inc VANI.O:
VIVANI MEDICAL PROVIDES UPDATE ON CLINICAL DEVELOPMENT PLANS FOR NPM-139 SEMAGLUTIDE IMPLANT FOR CHRONIC WEIGHT MANAGEMENT
VIVANI MEDICAL INC - TO INITIATE PHASE 1 STUDY FOR NPM-139 IN 2026
Source text: ID:nGNXbVZGZX
Further company coverage: VANI.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.